AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17473911 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (100,000 IU ergocalciferol every four months)
Number of subjects: 3440
Study 17473911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3440
Study 17473911 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 3440
Study 15878442 — intervention group
Group type: EXPERIMENTAL
Intervention: telithromycin 800 mg qd for 7-10 days
Number of subjects: 115
Study 12495265 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg curcumin
Number of subjects: 12
Study 12495265 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg curcumin
Number of subjects: 12
Study 12495265 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg curcumin
Number of subjects: 12
Study 9802626 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin for 5 days
Number of subjects: 420
Study 9802626 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate or erythromycin for 10 days (control)
Number of subjects: 420
Study 7706609 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (150 mg/day for 1 week, followed by 300 mg/day for 3 weeks)
Number of subjects: 8
Study 2615456 — intervention group
Group type: EXPERIMENTAL
Intervention: Yi‐qi Huo‐xue Injection (YHI)
Number of subjects: 0
Study 700592 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebeverine
Number of subjects: 30
Study 700592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31373782 — intervention group
Group type: EXPERIMENTAL
Intervention: Epicardial delivery of cardiopoietic stem cells (CP)
Number of subjects: 0
Study 31373782 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study 31129105 — intervention group
Group type: EXPERIMENTAL
Intervention: Swallowing disorders (SD)
Number of subjects: 340
Study 31129105 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchopneumonia (BP)
Number of subjects: 340
Study 31129105 — intervention group
Group type: EXPERIMENTAL
Intervention: NIHSS scores >4, involvement of the medulla oblongata, wearing a dental prosthesis
Number of subjects: 340
Study 31129105 — intervention group
Group type: EXPERIMENTAL
Intervention: NIHSS scores >4, male sex, bilateral cerebral lesions, presence of SD, use of an enteral feeding tube
Number of subjects: 340
Study 31129105 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of SD
Number of subjects: 340
Study 27699890 — intervention group
Group type: EXPERIMENTAL
Intervention: Megagen AnyRidge (AR) implant
Number of subjects: 7
Study 27699890 — intervention group
Group type: COMPARATOR
Intervention: Megagen EZ Plus Internal (EZ) implant
Number of subjects: 7
Study 25634244 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated family planning and HIV services
Number of subjects: 974
Study 25634244 — intervention group
Group type: COMPARATOR
Intervention: Standard referral-based system (control)
Number of subjects: 974
Study 23881185 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 50 mg/day
Number of subjects: 2189
Study 23881185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2189
Study 21766512 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum prohepcidin (pHp) levels
Number of subjects: 84
Study 21766512 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum iron (sFe)
Number of subjects: 84
Study 21766512 — intervention group
Group type: EXPERIMENTAL
Intervention: Total iron binding capacity (TIBC)
Number of subjects: 84
Study 21766512 — intervention group
Group type: EXPERIMENTAL
Intervention: Transferrin saturation
Number of subjects: 84
Study 21766512 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferritin
Number of subjects: 84
Study 21766512 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc-protoporphyrine (ZPP) in erythrocytes
Number of subjects: 84
Study 21766512 — intervention group
Group type: EXPERIMENTAL
Intervention: High sensitivity C-reactive protein (hs-CRP)
Number of subjects: 84
Study 18848434 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized capsule of Camellia sinensis (CSC)
Number of subjects: 111
Study 18848434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 18240698 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month scholarship to a structured commercial program
Number of subjects: 21
Study 18240698 — intervention group
Group type: COMPARATOR
Intervention: Weight management counseling (control)
Number of subjects: 21
Study 15723941 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone injections (4-mg/mL solution, 0.5 mL, once per week for 4 weeks)
Number of subjects: 36
Study 15723941 — intervention group
Group type: COMPARATOR
Intervention: Isotonic sodium chloride (saline) solution (0.5 mL, once per week for 4 weeks)
Number of subjects: 36
Study 11880081 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mL of 1% lidocaine in the lateral and apical periprostatic regions, 5 mL in each point, 10 minutes before the biopsy
Number of subjects: 152
Study 11880081 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lidocaine injection)
Number of subjects: 152
Study 9667276 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative therapy
Number of subjects: 507
Study 9667276 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative therapy
Number of subjects: 507
Study 9667276 — intervention group
Group type: EXPERIMENTAL
Intervention: Both preoperative and postoperative therapy
Number of subjects: 507
Study 9667276 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiation alone
Number of subjects: 507
Study 9667276 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 507
Study 9667276 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern radiation treatment techniques
Number of subjects: 507
Study 9667276 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trial participation
Number of subjects: 507
Study 9667276 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality therapy
Number of subjects: 507
Study 7640488 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiss Screen for Maladaptive Behavior
Number of subjects: 0
Study 2565697 — intervention group
Group type: EXPERIMENTAL
Intervention: Metipranolol (Bétanol) eye drops
Number of subjects: 12
Study 2565697 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol (Bétoptic) eye drops
Number of subjects: 12
Study 2565697 — intervention group
Group type: COMPARATOR
Intervention: Placebo (physiological saline)
Number of subjects: 12
Study 321002 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed rest and sedation
Number of subjects: 135
Study 321002 — intervention group
Group type: COMPARATOR
Intervention: Normal activity and non-sedation
Number of subjects: 135
Study 30601358 — intervention group
Group type: EXPERIMENTAL
Intervention: MC‐PMMA group
Number of subjects: 105
Study 30601358 — intervention group
Group type: COMPARATOR
Intervention: PMMA group
Number of subjects: 105
Study 30400876 — intervention group
Group type: EXPERIMENTAL
Intervention: STROKE-CARD multifaceted post-stroke disease management program
Number of subjects: 2160
Study 30400876 — intervention group
Group type: COMPARATOR
Intervention: Usual post-stroke patient care
Number of subjects: 2160
Study 26496937 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepackaged low-residue diet (PLD)
Number of subjects: 100
Study 26496937 — intervention group
Group type: COMPARATOR
Intervention: Restricted diet (RD)
Number of subjects: 100
Study 24513152 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI-informed EEG source-imaging
Number of subjects: 0
Study 22228322 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for moderate to severe hot flushes
Number of subjects: 710
Study 22228322 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 710
Study 20511018 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable heroin
Number of subjects: 127
Study 20511018 — intervention group
Group type: COMPARATOR
Intervention: Oral methadone
Number of subjects: 127
Study 20511018 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable methadone
Number of subjects: 127
Study 18173144 — intervention group
Group type: EXPERIMENTAL
Intervention: Fangchuan Mixture (FCM)
Number of subjects: 175
Study 18173144 — intervention group
Group type: EXPERIMENTAL
Intervention: Fangchuan Mixture + Flixotide (Group C)
Number of subjects: 175
Study 15711601 — intervention group
Group type: EXPERIMENTAL
Intervention: High dairy protein/high-calcium diet (DP, 2400 mg Ca/d)
Number of subjects: 50
Study 15711601 — intervention group
Group type: COMPARATOR
Intervention: High mixed protein/moderate calcium diet (MP, 500 mg Ca/d)
Number of subjects: 50
Study 15711601 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets (DP and MP)
Number of subjects: 50
Study 11801552 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical DFMO
Number of subjects: 48
Study 11801552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 10422932 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 2.5 mg with fentanyl 25 microg
Number of subjects: 90
Study 10422932 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 1.25 mg with fentanyl 25 microg
Number of subjects: 90
Study 10422932 — intervention group
Group type: COMPARATOR
Intervention: Plain fentanyl 25 microg
Number of subjects: 90
Study 7768495 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg pravastatin day-1 for 3 weeks
Number of subjects: 33
Study 7768495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 7768495 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 33
Study 2189394 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcervical chorion villus sampling
Number of subjects: 210
Study 2189394 — intervention group
Group type: COMPARATOR
Intervention: Transabdominal chorion villus sampling
Number of subjects: 210
Study 733132 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous penicillin and tetracycline
Number of subjects: 265
Study 733132 — intervention group
Group type: COMPARATOR
Intervention: Intravenous penicillin and intramuscular tobramycin
Number of subjects: 265
Study 733132 — intervention group
Group type: COMPARATOR
Intervention: Intact membranes
Number of subjects: 265
Study 733132 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruptured membranes for less than 6 hours
Number of subjects: 265
Study 31523039 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (12 mg, two intramuscular injections, 24 hours apart)
Number of subjects: 1346
Study 31523039 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone (11.4 mg, two intramuscular injections, 24 hours apart)
Number of subjects: 1346
Study 31523039 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 1346
Study 31523039 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone
Number of subjects: 1346
Study 28225684 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI at a magnetic field strength of 1.5 tesla
Number of subjects: 1500
Study 28225684 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat MRI
Number of subjects: 1500
Study 26087318 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined delayed cord clamping and umbilical cord milking
Number of subjects: 300
Study 26087318 — intervention group
Group type: COMPARATOR
Intervention: Milking of the cut cord
Number of subjects: 300
Study 26087318 — intervention group
Group type: COMPARATOR
Intervention: Delayed cord clamping
Number of subjects: 300
Study 23297919 — intervention group
Group type: EXPERIMENTAL
Intervention: Linguistic identification training task
Number of subjects: 60
Study 23297919 — intervention group
Group type: EXPERIMENTAL
Intervention: Indexical identification training task
Number of subjects: 60
Study 23297919 — intervention group
Group type: COMPARATOR
Intervention: Control group (passive exposure)
Number of subjects: 60
Study 21709597 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural cortical stimulation of the left dorsolateral prefrontal cortex
Number of subjects: 12
Study 21709597 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study 19192350 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist (0.25 mg per day) during endometrial priming with oestradiol (group I, n = 49)
Number of subjects: 98
Study 19192350 — intervention group
Group type: COMPARATOR
Intervention: Control group (group II, n = 49) receiving only endometrial preparation
Number of subjects: 98
Study 16783042 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole with alginate
Number of subjects: 26
Study 16783042 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole alone
Number of subjects: 26
Study 15235686 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin for 24 months
Number of subjects: 64
Study 15235686 — intervention group
Group type: COMPARATOR
Intervention: Standard anticoagulation for 6 months
Number of subjects: 64
Study 15235686 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study 11300425 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg once daily
Number of subjects: 133
Study 11300425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 9291556 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal adjustment
Number of subjects: 50
Study 9291556 — intervention group
Group type: COMPARATOR
Intervention: Counselling alone (Control)
Number of subjects: 50
Study 9291556 — intervention group
Group type: COMPARATOR
Intervention: Overall treatment (including counselling and occlusal adjustment)
Number of subjects: 50
Study 9291556 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intensity of pain (measured by visual analogue scale)
Number of subjects: 50
Study 9291556 — intervention group
Group type: EXPERIMENTAL
Intervention: Demand for rescue treatment
Number of subjects: 50
Study 8322777 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg/d)
Number of subjects: 21
Study 8322777 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg/d)
Number of subjects: 21
Study 8322777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 3539548 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional hyperthermic cytostatic perfusion with Melphalan (42 degrees C) in group B (n = 53)
Number of subjects: 107
Study 3539548 — intervention group
Group type: COMPARATOR
Intervention: Control group A (n = 54) with wide excision of tumors and regional lymph node dissection
Number of subjects: 107
Study 29631307 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual motivational intervention (HaLT‐Präventionsprojekt) in Group A (n=28)
Number of subjects: 48
Study 29631307 — intervention group
Group type: COMPARATOR
Intervention: No intervention in Group B (n=20)
Number of subjects: 48
Study 28695535 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of lurasidone (20, 40, and 80 mg)
Number of subjects: 100
Study 28695535 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of lurasidone (40 mg administered once daily for 5 days)
Number of subjects: 100
Study 28695535 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 25893562 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (CR) supplementation at 20 g day(‐1) during cast-immobilization
Number of subjects: 25
Study 25893562 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) during cast-immobilization
Number of subjects: 25
Study 23911535 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal Bolus regimen with glargine once daily and glulisine before meals
Number of subjects: 298
Study 23911535 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal Plus regimen with glargine once daily and supplemental doses of glulisine before meals
Number of subjects: 298
Study 23911535 — intervention group
Group type: COMPARATOR
Intervention: Medicine patients
Number of subjects: 298
Study 20842759 — intervention group
Group type: EXPERIMENTAL
Intervention: FITT-NH (telephone intervention)
Number of subjects: 46
Study 20842759 — intervention group
Group type: COMPARATOR
Intervention: Non-contact control (standard care)
Number of subjects: 46
Study 18422590 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate (RIS) 35 mg once weekly
Number of subjects: 44
Study 18422590 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (TPTD) 20 microg once daily
Number of subjects: 44
Study 18422590 — intervention group
Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 44
Study 16868481 — intervention group
Group type: EXPERIMENTAL
Intervention: Creon 10
Number of subjects: 0
Study 16868481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14976882 — intervention group
Group type: EXPERIMENTAL
Intervention: Large dosage of Salvia injection (24 ml)
Number of subjects: 64
Study 14976882 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle dosage of Salvia injection (16 ml)
Number of subjects: 64
Study 14976882 — intervention group
Group type: EXPERIMENTAL
Intervention: Small dosage of Salvia injection (8 ml)
Number of subjects: 64
Study 14976882 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Salvia injection)
Number of subjects: 64
Study 10970081 — intervention group
Group type: EXPERIMENTAL
Intervention: Full thickness skin graft repair
Number of subjects: 68
Study 10970081 — intervention group
Group type: COMPARATOR
Intervention: Partial thickness skin graft repair
Number of subjects: 68
Study 9085056 — intervention group
Group type: EXPERIMENTAL
Intervention: Double gloves
Number of subjects: 400
Study 9085056 — intervention group
Group type: COMPARATOR
Intervention: Single gloves
Number of subjects: 400
Study 7871061 — intervention group
Group type: EXPERIMENTAL
Intervention: Brofaromine (150 mg daily)
Number of subjects: 30
Study 7871061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 3609849 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion
Number of subjects: 15
Study 3609849 — intervention group
Group type: COMPARATOR
Intervention: D5NS infusion (Control)
Number of subjects: 15
Study 30701878 — intervention group
Group type: COMPARATOR
Intervention: macitentan 10 mg
Number of subjects: 742
Study 30701878 — intervention group
Group type: COMPARATOR
Intervention: macitentan
Number of subjects: 742
Study 26853501 — intervention group
Group type: EXPERIMENTAL
Intervention: guided meditation
Number of subjects: 121
Study 26853501 — intervention group
Group type: EXPERIMENTAL
Intervention: music
Number of subjects: 121
Study 26853501 — intervention group
Group type: COMPARATOR
Intervention: standard‐care control group
Number of subjects: 121
Study 25007166 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-grafted dialyzer
Number of subjects: 251
Study 25007166 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (regular saline flushes or pre-dilution)
Number of subjects: 251
Study 21911257 — intervention group
Group type: COMPARATOR
Intervention: 30 min full spectrum light (9000 lx, 5000 K)
Number of subjects: 52
Study 21911257 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min blue‐enriched light (9000 lx, 17,000 K)
Number of subjects: 52
Study 21911257 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 min blue‐enriched light
Number of subjects: 52
Study 20235450 — intervention group
Group type: EXPERIMENTAL
Intervention: Diplopore puncture of tympanum and intratympanic administration (DPTIA) combined with medication
Number of subjects: 141
Study 20235450 — intervention group
Group type: COMPARATOR
Intervention: Haplopore puncture of tympanum combined with medication
Number of subjects: 141
Study 18672766 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Wuhua Decoction (WHD) plus oral levocetirizine tablet
Number of subjects: 75
Study 18672766 — intervention group
Group type: COMPARATOR
Intervention: Levocetirizine tablet alone
Number of subjects: 75
Study 16096356 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper extremity disorders (neck, shoulder, hand)
Number of subjects: 17669
Study 16096356 — intervention group
Group type: EXPERIMENTAL
Intervention: Job content, physical working condition, interpersonal relationships, organizational problems
Number of subjects: 17669
Study 16096356 — intervention group
Group type: EXPERIMENTAL
Intervention: Male workers in manufacturing industries
Number of subjects: 17669
Study 16096356 — intervention group
Group type: EXPERIMENTAL
Intervention: Female workers in public administration
Number of subjects: 17669
Study 11818308 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 0
Study 11291373 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-directed program featuring mailed booklets and telephone contacts by health educators
Number of subjects: 0
Study 11291373 — intervention group
Group type: COMPARATOR
Intervention: No family-directed program (control group)
Number of subjects: 0
Study 9372530 — intervention group
Group type: EXPERIMENTAL
Intervention: quetiapine (300-700 mg/day)
Number of subjects: 18
Study 9372530 — intervention group
Group type: EXPERIMENTAL
Intervention: clozapine (300-600 mg/day)
Number of subjects: 18
Study 9372530 — intervention group
Group type: COMPARATOR
Intervention: haloperidol (10-20 mg/day)
Number of subjects: 18
Study 9372530 — intervention group
Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 18
Study 8501142 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg alendronate
Number of subjects: 65
Study 8501142 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg alendronate
Number of subjects: 65
Study 8501142 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg alendronate
Number of subjects: 65
Study 8501142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 8501142 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (all doses)
Number of subjects: 65
Study 3687038 — intervention group
Group type: EXPERIMENTAL
Intervention: Canrenon with hydrochlorothiazide (HCT)
Number of subjects: 0
Study 3687038 — intervention group
Group type: COMPARATOR
Intervention: Comparison product available on the market
Number of subjects: 0
Study 29802965 — intervention group
Group type: EXPERIMENTAL
Intervention: HABITS intervention (habit formation focusing on improving fruits/vegetables, fried foods, sugar-sweetened beverages, physical activity, and self-monitoring)
Number of subjects: 298
Study 29802965 — intervention group
Group type: COMPARATOR
Intervention: Existing home visitation services without obesity-related content
Number of subjects: 298